The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Prevalence of risk factors in men with premature coronary artery disease
Abstract
The prevalence of modifiable cardiovascular risk factors (systemic hypertension, diabetes mellitus, cigarette smoking, low-density lipoprotein [LDL] cholesterol greater than or equal to 160 mg/dl and high-density lipoprotein [HDL] cholesterol less than 35 mg/dl) was determined in 321 men less than 60 years of age (mean +/- standard deviation 50 +/- 7) with premature coronary artery disease (CAD) documented at coronary angiography. The prevalence of these risk factors was markedly different than in the Framingham Offspring Study population, used here as a comparison group. In the patients with CAD, only 3% had no risk factor (other than male sex), compared with 31% in the Framingham Offspring Study subjects. Most patients with CAD (97%) had greater than or equal to 1 additional risk factor. When the patients with CAD were divided by age groups (40 to 49 years [n = 109], 50 to 59 [n = 191]), no significant differences were observed in the prevalence of risk factors between the young and older patients. The prevalence of systemic hypertension (41 vs 19%, p less than 0.001), diabetes mellitus (12 vs 1.1%, p less than 0.001), cigarette smoking (67 vs 28%, p less than 0.001) and HDL cholesterol less than 35 mg/dl (63 vs 19%, p less than 0.001) was markedly higher in the patients with CAD than in Framingham Offspring Study subjects, whereas the prevalence of LDL cholesterol greater than or equal to 160 mg/dl was not significantly different between patients with CAD and Framingham Offspring Study subjects (26 vs 26%).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with manifest CHD frequently exhibit low HDL cholesterol (HDL-C) [2].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [2]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
Multiple Risk Factor Intervention Trial
Michel, D. (1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 2,211
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Clofibrate and Niacin in Coronary Heart Disease
Stamler, J. (1975) · JAMA · doi:10.1001/jama.1975.03240160024021 · Cited by 1,750
Quantitative Effects of Dietary Fat on Serum Cholesterol in Man
Hegsted, D. M., McGandy, R. B., Myers, M. L., & Stare, F. J. (1965) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/17.5.281 · Cited by 1,589
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
The Lipid Research Clinics Coronary Primary Prevention Trial Results
(1984) · JAMA · doi:10.1001/jama.1984.03340270043026 · Cited by 1,404
Research works printed but not linked: 2
- 1988, Can Med Assoc J, 138, 1
- Warnick, 1982, Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol, Clin Chem, 79, 93
Cited by
Sorted by citations
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Self-citationEffects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Self-citationHigh Density Lipoproteins and Arteriosclerosis
von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696
Carr, M. C., & Brunzell, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0432 · Cited by 493
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Linsel‐Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 489
Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 465
Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 436
Self-citationABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR
Schwartz, K., Lawn, R. M., & Wade, D. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3243 · Cited by 410
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 404
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298
HDL cholesterol: reappraisal of its clinical relevance
März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275
Homozygous Tangier disease and cardiovascular disease
Serfaty-Lacrosnière, C., Civeira, F., Lanzberg, A., Isaia, P., Berg, J., Janus, E. D., Smith, M. P., Pritchard, P. H., Frohlich, J., Lees, R. S., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90144-9 · Cited by 261
Self-citationSt-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., Bernard, P., Després, J., & Lamarche, B. (2001) · Circulation · doi:10.1161/hc4401.098490 · Cited by 259
Schaefer, E. J., Lamon‐Fava, S., Cohn, S. D., Schaefer, M. M., Ordovás, J. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39173-2 · Cited by 259
Self-citationChapman, M. J., Assmann, G., Fruchart, J., Shepherd, J., & Sirtori, C. R. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004402 · Cited by 257
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study
Capuzzi, D. M., Guyton, J. R., Morgan, J. M., Goldberg, A. C., Kreisberg, R. A., Brusco, O. A., & Brody, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00731-0 · Cited by 254
Distribution of lipids in 8,500 men with coronary artery disease
Bloomfield, H. E., Robins, S. J., Collins, D. E., Iranmanesh, A., Wilt, T. J., Mann, D. L., Mayo‐Smith, M. F., Faas, F. H., Elam, M. B., Rutan, G. H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80761-9 · Cited by 238
Wang, N., Ranalletta, M., Matsuura, F., Peng, F., & Tall, A. R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000218998.75963.02 · Cited by 220
Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 226
PPARα in atherosclerosis and inflammation
Zandbergen, F. J., & Plutzky, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.021 · Cited by 219
A Reexamination of Smoking Before, During, and After Pregnancy
Kahn, R. S., Certain, L., & Whitaker, R. C. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.11.1801 · Cited by 216
Schaefer, E. J., Lamon‐Fava, S., Ordovás, J. M., Cohn, S. D., Schaefer, M. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39181-1 · Cited by 200
Self-citationLamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170
Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population
Qureshi, A. I., Suri, M. F. K., Guterman, L. R., & Hopkins, L. N. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1621 · Cited by 149
Ruel, G., Pomerleau, S., Couture, P., Lamarche, B., & Couillard, C. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.031 · Cited by 148
Fibrates, dyslipoproteinaemia and cardiovascular disease
Watts, G. F., & Dimmitt, S. B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00011 · Cited by 146
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
Natarajan, S., Glick, H. A., Criqui, M. H., Horowitz, D., Lipsitz, S. R., & Kinosian, B. P. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00092-8 · Cited by 142
Guay, S., Brisson, D., Munger, J., Lamarche, B., Gaudet, D., & Bouchard, L. (2012) · Epigenetics · doi:10.4161/epi.19633 · Cited by 137
Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134
Newer perspectives of coronary artery disease in young
Aggarwal, A., Srivastava, S., & Velmurugan, M. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i12.728 · Cited by 135
Triglycerides and HDL Cholesterol
Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s343 · Cited by 132
Franceschini, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02146-4 · Cited by 131
Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting
Cziraky, M. J., Watson, K. E., & Talbert, R. L. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s8-a.1 · Cited by 134
Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05653-x · Cited by 129
Clustering of cardiovascular risk factors: Targeting high-risk individuals
Genest, J. J., & Cohn, J. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80010-4 · Cited by 123
Self-citationGenetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids
Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118
Obesity‐related Changes in High‐density Lipoprotein Metabolism
Mooradian, A. D., Haas, M. J., Wehmeier, K. R., & Wong, N. C. W. (2008) · Obesity · doi:10.1038/oby.2008.202 · Cited by 115
The physiology of lipoproteins
Tulenko, T. N., & Sumner, A. E. (2002) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2002.128959 · Cited by 113
Trans-fatty acid patterns in patients with angiographically documented coronary artery disease
Siguel, E. N., & Lerman, R. H. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90906-s · Cited by 114
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease
Srivastava, R. A. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3165-z · Cited by 113
Pearson, T. A., & Peters, T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00820-5 · Cited by 109
Postprandial inflammation and endothelial dysfuction
Alipour, A., Elte, J. W. F., van Zaanen, H. C. T., Rietveld, A. P., & Cabezas, M. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350466 · Cited by 108
Comparative effects of lipid-lowering therapies
Davidson, M. H., & Toth, P. P. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.007 · Cited by 106
Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate
Gan, X., Kaplan, R. A., Menke, J. G., MacNaul, K. L., Chen, Y., Sparrow, C. P., Zhou, G., Wright, S. D., & Cai, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109402200 · Cited by 101
Campos, H., Roederer, G. O., Lussier‐Cacan, S., Davignon, J., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1043 · Cited by 101
Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99
Self-citationParodi, P. W. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.01.001 · Cited by 99
Lipid transfer proteins (LTP) and atherosclerosis
Stein, O. T., & Stein, Y. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.008 · Cited by 96
Marcil, M., Yu, L., Krimbou, L., Boucher, B., Oram, J. F., Cohn, J. S., & Genest, J. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.159 · Cited by 89
Self-citationPremature myocardial infarction: Clinical profile and angiographic findings
Pineda, J., Marín, F. R., Roldán, V., Valencia, J., Marco, P., & Sogorb, F. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.038 · Cited by 88
Aguíar, C., Alegría, E., Bonadonna, R. C., Catapano, A. L., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hâncu, N., et al. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)30001-5 · Cited by 84
Clustering of Risk Factors for Coronary Heart Disease The Longitudinal Relationship with Lifestyle
Twisk, J. W. R. (2001) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00202-7 · Cited by 84
Baroni, M. G., D’Andrea, M. P., Montali, A., Pannitteri, G., Barillà, F., Campagna, F., Mazzei, E. M. E., Lovari, S., Seccareccia, F., Campa, P. P., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2975 · Cited by 83
Brscic, E., Bergerone, S., Gagnor, A., Colajanni, E., Matullo, G., Scaglione, L., Cassader, M., Gaschino, G., Leo, M. D., Brusca, A., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106165 · Cited by 80
High Density Lipoproteins in Health and in Disease
Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80
Self-citationLow HDL-C: A secondary target of dyslipidemia therapy
Rosenson, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.021 · Cited by 81
Li, A. C., & Palinski, W. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141247 · Cited by 77
Mott, S., Yu, L., Marcil, M., Boucher, B., Rondeau, C., & Genest, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00498-0 · Cited by 77
Self-citationDiurnal triglyceride profiles: a novel approach to study triglyceride changes
Cabezas, M. C., Halkes, C. J. M., Meijssen, S., van Oostrom, A. J. H. H. M., & Erkelens, D. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00554-2 · Cited by 75
Low High-Density Lipoprotein Cholesterol
Hersberger, M., & von Eckardstein, A. (2003) · Drugs · doi:10.2165/00003495-200363180-00003 · Cited by 74
Koba, S., Hirano, T., Kondo, T., Shibata, M., Suzuki, H., Murakami, M., Geshi, E., & Katagiri, T. (2002) · American Heart Journal · doi:10.1067/mhj.2002.126119 · Cited by 73
Peloso, G. M., Demissie, S., Collins, D. E., Mirel, D. B., Gabriel, S., Cupples, L. A., Robins, S. J., Schaefer, E. J., & Brousseau, M. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p008268 · Cited by 71
Self-citationKoba, S., Hirano, T., Yoshino, G., Sakai, K., Sakaue, T., Adachi, M., & Katagiri, T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00580-9 · Cited by 69
Familial lipoprotein disorders and premature coronary artery disease
Schaefer, E. J., Genest, J. J., Ordovás, J. M., Salem, D. N., & Wilson, P. W. F. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90152-x · Cited by 68
Self-citationLipaemia, Inflammation and Atherosclerosis
van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 67
Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data
Fredenrich, A., & Bayer, P. M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70029-0 · Cited by 65
Altered fatty acid metabolism in patients with angiographically documented coronary artery disease
Siguel, E. N., & Lerman, R. H. (1994) · Metabolism · doi:10.1016/0026-0495(94)90178-3 · Cited by 64
Jukema, J. W., Liem, A. H., Dunselman, P. H. J. M., van der Sloot, J. A. P., Lok, D. J. A., & Zwinderman, A. H. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x74952 · Cited by 61
Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport
Lesná, I. K., Suchánek, P., Kovář, J., Stávek, P., & Poledne, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800271-jlr200 · Cited by 60
Lee, C. Y., Krimbou, L., Vincent, J., Bernard, C., Larramée, P., Genest, J. J., & Marcil, M. (2003) · Human Genetics · doi:10.1007/s00439-002-0893-1 · Cited by 54
Self-citationvan Oostrom, A. J. H. H. M., Cabezas, M. C., Ribalta, J., Masana, L., Twickler, T. B., Remijnse, T. A. W., & Erkelens, D. W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00732.x · Cited by 57
CETP inhibition in cardiovascular risk management: a critical appraisal
Dullaart, R. P. F., Dallinga‐Thie, G. M., Wolffenbuttel, B. H. R., & van Tol, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01756.x · Cited by 54
Hunninghake, D. B., Maki, K. C., Kwiterovich, P. O., Davidson, M. H., Dicklin, M. R., & Kafonek, S. D. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718931 · Cited by 52
Dullaart, R. P. F., & Sluiter, W. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.6.747 · Cited by 52
Kaplan, R. A., Gan, X., Menke, J. G., Wright, S. D., & Cai, T. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30470-3 · Cited by 51
LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention
Sirtori, C. R., & Fumagalli, R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.024 · Cited by 50
Räihä, I. J., Marniemi, J., Puukka, P. J., Toikka, T., Ehnholm, C., & Sourander, L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1224 · Cited by 51
Guay, S., Voisin, G., Brisson, D., Munger, J., Lamarche, B., Gaudet, D., & Bouchard, L. (2012) · Epigenomics · doi:10.2217/epi.12.62 · Cited by 53
Li, Z., Yang, R., Xu, G., & Xia, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038646 · Cited by 51
Rosenson, R. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.049 · Cited by 50
Bersot, T. P., Pépin, G. M., & Mahley, R. W. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00516-7 · Cited by 45
Després, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 44
Cardiovascular Death in Dialysis Patients
Sniderman, A. D., Solhpour, A., Alam, A., Williams, K., & Sloand, J. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06300909 · Cited by 43
Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?
Badimón, J. J., Santos‐Gallego, C. G., & Badimón, L. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70150-0 · Cited by 45
Hosseini, S. K., Soleimani, A., Karimi, A., Sadeghian, S., Darabian, S., Abbasi, S. H., Ahmadi, S. H., Zoroufian, A., Mahmoodian, M., & Abbasi, A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2009.331 · Cited by 42
Bergheanu, S. C., van Tol, A., Dallinga‐Thie, G. M., Liem, A. H., Dunselman, P. H. J. M., van der Bom, J. G., & Jukema, J. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226104 · Cited by 41
Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
Boffa, M. B., & Koschinsky, M. L. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0360-6 · Cited by 38
Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients
Haidari, M., Moghadam, M., Chinicar, M., Ahmadieh, A., & Doosti, M. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00192-8 · Cited by 38
Utarwuthipong, T., Komindr, S., Pakpeankitvatana, V., Songchitsomboon, S., & Thongmuang, N. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700111 · Cited by 38
Alagona, P. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6714 · Cited by 40
Santos, R. D., Asztalos, B., Martinez, L., Miname, M., Polisecki, E., & Schaefer, E. (2008) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2008.06.002 · Cited by 40
Self-citationMukherjee, R., Locke, K. T., Miao, B., Meyers, D. S., Monshizadegan, H., Zhang, R., Search, D. J., Grimm, D., Flynn, M. A., O’Malley, K. M., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143271 · Cited by 38
Severe Familial HDL Deficiency in French-Canadian Kindreds
Marcil, M., Boucher, B., Krimbou, L., Solymoss, B., Davignon, J., Frohlich, J. J., & Genest, J. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1015 · Cited by 35
Self-citationIvanova, D. G., Tasinov, O., & Kiselova-Kaneva, Y. D. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.898256 · Cited by 35
The prevention of cardiovascular disease: Emphasis on Secondary Prevention
Robinson, J. G., & Leon, A. S. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30177-8 · Cited by 34
The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
Després, J. (1993) · Europe PMC (PubMed Central) · Cited by 34
The effects of sex, metabolic syndrome and exercise on postprandial lipemia
Cox‐York, K. A., Sharp, T. A., STOTZ, S. A., Bessesen, D. H., Pagliassotti, M. J., & Horton, T. J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.003 · Cited by 34
Myocardial infarction in the young: a sex-based comparison
Sozzi, F. B., Danzi, G. B., Foco, L., Ferlini, M., Marco Tubaro, U., Galli, M., Celli, P., & Mannucci, P. M. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583bfc · Cited by 32
Metadata
- Authors
- Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J.
- Affiliations
- Tufts University (US)
- Corresponding author
- Schaefer, Ernst J.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1991-06
- Volume
- 67
- Issue
- 15
- Pages
- 1185-1189
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2041225533
- Cited by
- 243
- References
- 28
- Citations by year
- 2023: 2 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 8 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 9 · 2013: 6 · 2012: 10
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl035243-03)
- National Heart, Lung, and Blood Institute (HL 35243)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- premature coronary artery disease, cardiovascular risk factors, men, systemic hypertension, diabetes mellitus, cigarette smoking, LDL cholesterol, HDL cholesterol, beta-blockers, Framingham Offspring Study, National Cholesterol Education Program guidelines, triglycerides, coronary angiography, young adults, risk factor prevalence
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Humans, Hypertension, Cholesterol, HDL, Cholesterol, LDL, Male, Massachusetts, Middle Aged, Risk Factors, Smoking, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review